Park Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Park Capital Management's ABBV Position: Q3 2026 in Review
Park Capital Management reduced its AbbVie (ABBV) stake by 7.2% in Q3 2026, selling an estimated $19.2K and leaving 971 shares worth $254K. The position accounts for 0.13% of the portfolio, ranked #148.
Park Capital Management first reported a position in ABBV in Q3 2025 and has held it in 5 quarters since. The position peaked at $263K in Q2 2026. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Park Capital Management held 971 shares of AbbVie worth $254K as of Q3 2026.
- Park Capital Management sold 75 AbbVie shares in Q3 2026, an estimated $19.2K.
- AbbVie made up 0.13% of Park Capital Management's portfolio in Q3 2026, its #148 holding.
- Park Capital Management first reported a position in AbbVie in Q3 2025 and has held it in 5 quarters since.
- Park Capital Management's AbbVie position peaked at $263K in Q2 2026.
- 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Park Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.